INSYS Therapeutics, Inc.

NASDAQ: INSYHealthcare / Biotechnology / USA
0.3400-0.0600-15.00%Vol 8 317 5101Y Perf -95.56%
Jun 14th, 2019 16:00
BID0.3300 ASK0.3800
Open0.4000 Previous Close0.4000
Pre-Market- After-Trading0.35
 - -%  0.01 2.94%
Target Price
5.20 
Analyst Rating
Moderate Buy 2.40
Potencial %
1 429.41 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★★★     51.33
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)25 
Earnings Rating
Neutral
Price Range Ratio 52wk %
1.74 
Earnings Date
14th May 2019

Today's Price Range

0.31000.4300

52wk Range

0.140011.65

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-71.43%
3 Months
-91.79%
6 Months
-93.08%
1 Year
-95.56%
3 Years
-97.45%
5 Years
-97.37%

Name / TickerPriceChg.Chg.%
INSY0.3400-0.0600-15.00
AAPL192.74-1.4100-0.73
GOOG1 085.35-3.4200-0.31
MSFT132.450.13000.10
XOM74.35-0.3300-0.44
WFC45.590.30000.66
JNJ140.09-0.6200-0.44
FB181.333.86002.18
GE10.23-0.0800-0.78
JPM109.820.28000.26
Earnings HistoryEstimateReportedSurprise %
Q01 2019--0.58-
Q04 2018-0.33-0.39-18.18
Q03 2018-0.32-0.40-25.00
Q02 2018-0.25-0.37-48.00
Q01 2018-0.24-0.228.33
Q04 2017--0.23-
Q03 2017-0.23-0.25-8.70
Q02 2017-0.09-0.0188.89
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.330.00-
12/2018 QR-0.32-45.45Negative
12/2019 FY-1.550.00-
12/2020 FY-0.880.00-
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %20.00
Volume Overview
Volume8 317 510
Shares Outstanding (in ths.)74 569
Trades Count6 545
Dollar Volume2 738 603
Avg. Volume2 495 417
Avg. Weekly Volume29 518 178
Avg. Monthly Volume8 880 395
Avg. Quarterly Volume3 532 526
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (40.00 %)
3 (60.00 %)
3 (60.00 %)
Moderate Buy
1 (20.00 %)
1 (20.00 %)
1 (20.00 %)
Hold
1 (20.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
1 (20.00 %)
1 (20.00 %)
1 (20.00 %)
RatingModerate Buy
2.40
Moderate Buy
2.00
Moderate Buy
2.00

INSYS Therapeutics, Inc.

Insys Therapeutics Inc is a specialty pharmaceutical company. It develops and commercializes innovative drugs and novel drug delivery systems of therapeutic molecules that improve patients' quality of life. The company have two marketed products; SUBSYS, a proprietary sublingual fentanyl spray; and SYNDROS, a proprietary orally administered liquid formulation of dronabinol. The company derives revenue from selling SUBSYS and SYNDROS in various dosing packages to wholesale pharmaceutical distributors and specialty retail pharmacies, on a wholesale basis.

CEO: Andrew G. Long

Teplephone: +1 480 500-3127

Address: 1333 South Spectrum Boulevard, Chandler 85286, AZ, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

52%48%

Bearish Bullish

59%41%

News